Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Micafungin vs Liposomal Amphotericin B in Invasive Candidiasis
NCT00106288Phase 3Completed
- Sponsor
- Astellas Pharma
- Start
- Jan 2003
- Primary completion
- Dec 2005
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of micafungin in invasive candidiasis, candidemia, sponsored by Astellas Pharma. Started Jan 2003; status: completed.
02
Drugs
micafungin
03
Conditions
invasive candidiasiscandidemia
Beyond the preview
Go deeper on NCT00106288.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00106288.